Food and Drug Administration (FDA) approved Zepbound for chronic weight management
Across published clinical trial work, researchers have studied it for weight management, weight reduction, body composition, fat loss, appetite suppression, and broader metabolic regulation, with reported doses up to 12mg by subcutaneous injection
The Retatrutide starting dose of 2 mg per week applies broadly across its uses
The prevalence of grades 2 and 3 obesity (BMI 35 and 40 kg/m 2 , respectively) is about twice as high in women than in men (9, 10)
Side-by-Side Comparison Dosing Comparison The figures below are community-reported patterns, not dosing instructions